TY - JOUR
AU1 - Bozzetto, Lutgarda
AU2 - De Angelis, Raffaele
AU3 - Calabrese, Ilaria
AU4 - Giglio, Clemente
AU5 - Annuzzi, Giovanni
AB - 1050653 DSTXXX10.1177/19322968211050653Journal of Diabetes Science and TechnologyBozzetto et al. letter2021 Letter to the Editor Journal of Diabetes Science and Technology 2022, Vol. 16(1) 264 –265 © 2021 Diabetes Technology Society Clinical Outcomes of Remote Article reuse guidelines: sagepub.com/journals-permissions Training for Advanced Diabetes https://doi.org/10.1177/19322968211050653 DOI: 10.1177/19322968211050653 journals.sagepub.com/home/dst Technologies During the COVID-19 Pandemic 1 1 Lutgarda Bozzetto, MD, PhD , Raffaele De Angelis, MD , 1 1 Ilaria Calabrese, RD, PhD , Clemente Giglio, MD , and Giovanni Annuzzi, MD Keywords Continuous Glucose Monitoring, Continuous Subcutaneous Insulin Infusion, hybrid artificial pancreas, telemedicine, type 1 diabetes New technologies for managing type 1 diabetes (T1D) offer were observed in both groups (Table 1). The coefficient of vari- health care providers (HCPs) a means to minimize face-to- ation significantly improved only in the remote training group. face visits and, consequently, COVID-19 exposure and The changes in outcomes were not significantly different missed time from work and school. To align with COVID- between groups (Table 1). 19 pandemic restrictions, a remote training program was This study shows that remote training for closed-loop implemented in March 2020 at the Federico II University onboarding was as effective as face-to-face training in achiev- Hospital diabetes center, to onboard 
TI - Clinical Outcomes of Remote Training for Advanced Diabetes Technologies During the COVID-19 Pandemic
JF - Journal of Diabetes Science and Technology
DO - 10.1177/19322968211050653
DA - 2022-01-01
UR - https://www.deepdyve.com/lp/sage/clinical-outcomes-of-remote-training-for-advanced-diabetes-Uys7hVjVZa
SP - 264
EP - 265
VL - 16
IS - 1
DP - DeepDyve
ER -